NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

Verition Fund Management LLC's Holding History (CIK: 0001454027)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 32,391 Value ($000) $1,136 Avg Close $36.39 Range $28.19 - $42.00

Q3 2025

Shares 13,828 Value ($000) $393 Avg Close $23.97 Range $17.97 - $28.91

Q2 2025

Shares 13,828 Value ($000) $250 Avg Close $18.24 Range $14.06 - $22.25

Q1 2025

Shares 50,472 Value ($000) $1,033 Avg Close $22.23 Range $17.18 - $26.80

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	32,391	$1,136	$36.39	$28.19 - $42.00
Q3 2025	13,828	$393	$23.97	$17.97 - $28.91
Q2 2025	13,828	$250	$18.24	$14.06 - $22.25
Q1 2025	50,472	$1,033	$22.23	$17.18 - $26.80